CA
REGN icon

Cetera Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Cetera Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.02M Buy
5,218
+2,781
+114% +$2.64M 0.04% 459
2023
Q4 		$2.14M Buy
2,437
+72
+3% +$59.3K 0.03% 479
2023
Q3 		$1.95M Buy
2,365
+3
+0.1% +$2.36K 0.03% 474
2023
Q2 		$1.7M Buy
2,362
+175
+8% +$135K 0.03% 519
2023
Q1 		$1.8M Buy
2,187
+8
+0.4% +$6.03K 0.03% 486
2022
Q4 		$1.57M Buy
2,179
+298
+16% +$220K 0.03% 515
2022
Q3 		$1.3M Sell
1,881
-222
-11% -$140K 0.03% 459
2022
Q2 		$1.24M Buy
2,103
+124
+6% +$80.6K 0.03% 503
2022
Q1 		$1.38M Buy
1,979
+56
+3% +$35.4K 0.03% 507
2021
Q4 		$1.21M Sell
1,923
-45
-2% -$27.7K 0.02% 532
2021
Q3 		$1.19M Buy
1,968
+164
+9% +$102K 0.02% 550
2021
Q2 		$1.01M Sell
1,804
-10
-0.6% -$5.07K 0.02% 542
2021
Q1 		$858K Buy
1,814
+399
+28% +$194K 0.02% 540
2020
Q4 		$684K Buy
1,415
+880
+164% +$475K 0.02% 529
2020
Q3 		$299K Sell
535
-274
-34% -$166K 0.01% 728
2020
Q2 		$505K Sell
809
-630
-44% -$358K 0.02% 530
2020
Q1 		$703K Buy
+1,439
New +$594K 0.04% 383
2018
Q4 		– Sell
-952
Closed -$382K – 943
2018
Q3 		$382K Buy
+952
New +$362K 0.02% 652
2015
Q4 		– Sell
-743
Closed -$347K – 760
2015
Q3 		$347K Buy
743
+50
+7% +$26.9K 0.03% 450
2015
Q2 		$359K Sell
693
-2
-0.3% -$976 0.03% 459
2015
Q1 		$316K Buy
695
+180
+35% +$76.3K 0.03% 490
2014
Q4 		$211K Buy
+515
New +$203K 0.02% 587
2013
Q4 		– Sell
-670
Closed -$210K – 520
2013
Q3 		$210K Buy
+670
New +$176K 0.04% 398

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cetera Advisors's REGN Position: Q1 2024 in Review

Cetera Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 114% in Q1 2024, buying an estimated $2.64M and bringing the position to 5,218 shares worth $5.02M. The position accounts for 0.04% of the portfolio, ranked #459.

Cetera Advisors first reported a position in REGN in Q3 2013 and has held it in 23 quarters since. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Cetera Advisors held 5,218 shares of Regeneron Pharmaceuticals worth $5.02M as of Q1 2024.
  • Cetera Advisors bought 2,781 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $2.64M.
  • Regeneron Pharmaceuticals made up 0.04% of Cetera Advisors's portfolio in Q1 2024, its #459 holding.
  • Cetera Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 23 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.